KITHER BIOTECH
Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases. In recent years Kither has focused its first line of activities on the development of a small peptide (KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 pep... tide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development. Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule.
KITHER BIOTECH
Industry:
Biopharma Biotechnology Life Science
Founded:
2018-01-01
Address:
Torino, Piemonte, Italy
Country:
Italy
Website Url:
http://www.kitherbiotech.com
Total Employee:
1+
Status:
Active
Total Funding:
24.1 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Advisors List
Current Employees Featured
Founder
Investors List
Italian Angels for Growth
Italian Angels for Growth investment in Series B - Kither Biotech
Claris Ventures
Claris Ventures investment in Series B - Kither Biotech
3B Future Health Fund
3B Future Health Fund investment in Series B - Kither Biotech
CDP Venture Capital
CDP Venture Capital investment in Series B - Kither Biotech
Club degli Investitori
Club degli Investitori investment in Series B - Kither Biotech
Ace Ventures
Ace Ventures investment in Series B - Kither Biotech
Ersel
Ersel investment in Series B - Kither Biotech
2invest
2invest investment in Series B - Kither Biotech
Alef 6
Alef 6 investment in Series B - Kither Biotech
Claris Ventures
Claris Ventures investment in Series A - Kither Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-16 | Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer |
Official Site Inspections
http://www.kitherbiotech.com Semrush global rank: 5.41 M Semrush visits lastest month: 1.56 K
- Host name: 207.188.214.35.bc.googleusercontent.com
- IP address: 35.214.188.207
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Kither Biotech"
Company Overview - Kither Biotech
Company overview Company overview Kither Biotech is biopharmaceutical company developing signal transduction modulators for the treatments of rare respiratory diseases. Kither Biotech was founded in November 2011 as a spin …See details»
Company overview - Kither Biotech
Company overview Company overview Kither Biotech is biopharmaceutical company with the mission of identifying and developing new drug candidates for the treatment of rare pulmonary …See details»
Kither Biotech - Crunchbase Company Profile & Funding
Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development …See details»
Kither Biotech s.r.l. - VentureRadar
"Kither Biotech is a spin-off company from the University of Turin focusing on the development of new treatments for pulmonary diseases, with specific focus on cystic fibrosis and idiopathic …See details»
Kither Biotech - LinkedIn
Kither Biotech | 1,615 followers on LinkedIn. Improving treatment for patients suffering from incurable respiratory diseases | Kither Biotech is a biopharmaceutical company that develops novel ...See details»
KITHER BIOTECH SRL Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for KITHER BIOTECH SRL of TORINO, TORINO. Get the latest business insights from Dun & Bradstreet.See details»
Kither Biotech Company Profile 2024: Valuation, …
Kither Biotech General Information Description. Developer of anticancer and anti-inflammation drugs intended for pulmonary diseases with unmet medical needs. The company provides services in drugs that are researched for the treatment …See details»
Kither Biotech Raises €18.5 Million Series B and Appoints
Mar 16, 2022 Consilium Strategic Communications Matthew Cole / Davide Salvi / Lucie Foster [email protected]: Tel: +44 (0) 20 3709 5700See details»
Kither Biotech raises a €5.6m financing round to support
Jul 9, 2019 Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases Turin (Italy) – 5 July, 2019 – Kither …See details»
Emilio Hirsch - Kither Biotech
Back to Team Emilio Hirsch Emilio Hirsch is Professor of Experimental Biology in the Medical School, University of Torino since 2005. He has authored more than 200 scientific publications that received more than 18000 citations. He is an …See details»
Kither Biotech Raises €18.5 Million Series B and Appoints Dr.
Mar 16, 2022 Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Proceeds to support the further development of lead asset KIT2014 in …See details»
Kither Biotech - Craft
Kither Biotech is a pharmaceutical product company that develops drugs to treat chronic inflammatory diseases. One of its products is a small peptide (KIT2014) developed internally …See details»
Kither Biotech - Italian Tech
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer; Kither Biotech raises a €5.6m financing round to support the clinical development of a …See details»
Kither Biotech Company Information - Funding, Investors, and More
Jan 1, 2022 Get information on funding, investors, industries, and more for Kither Biotech. See Kither Biotech company profile and funding data.See details»
Team - Kither Biotech
Team Meet Our Team Dimitrios Goundis Executive DirectorRead More Marco Kevin Malisani Executive DirectorRead More Valentina Sala Head of Scientific AffairsRead More Carla …See details»
Kither Biotech announces publication of new data in Science
Mar 31, 2022 Consilium Strategic Communications Matthew Cole / Davide Salvi / Lucie Foster [email protected]: Tel: +44 (0) 20 3709 5700See details»
KITHER BIOTECH ANNOUNCES PHASE 1 CLINICAL STUDY OF
Oct 30, 2024 Study to evaluate the safety and tolerability of KIT2014, an inhaled peptide therapy designed to enhance Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) …See details»
Drug development - Kither Biotech
Drug development Kither Biotech is developing drugs that target the PI3K signalling pathway, for the treatment of rare respiratory diseases like cystic fibrosis (CF) and idiopathic pulmonary …See details»
Press releases - Kither Biotech
Turin, Italy, 31 March 2022 – Data support the use of Kither Biotech’s lead asset, KIT2014, in obstructive airway diseases…See details»